Company intelligence / Profile preview

Advancit Capital

Norwood, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Advancit Capital is a private venture capital firm that invests primarily in media, entertainment, technology, and web3 startups. The firm is not a biotechnology, pharmaceutical, healthcare services, or life sciences operating company; rather, it is an investor with a broad venture portfolio that has included some health-tech exposures alongside its core media and technology focus. Founded in 2011, Advancit is associated with Shari Redstone and Jason Ostheimer and operates as an active early-stage investment platform. For biotech analyst purposes, Advancit should be classified as a financial sponsor rather than a drug developer, healthcare operator, or platform therapeutics company.

Industry: Investors

Beyond the preview

Go deeper on Advancit Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advancit Capital.

Explore the full profile